Clinical Trial: Low Intensity Shockwave Therapy for Erectile Dysfunction
It is estimated that about 1 in 10 men suffer from erectile dysfunction (ED). Ryan P. Smith, MD, UVA urologist, is leading a clinical trial to test low-intensity shockwave therapy as a potential treatment for ED
Who is eligible to participate?
- Men who currentlv suffer from ED
- Patients who have undergone treatment for prostate cancer and have ED.
- Patients who are planning to undergo treatment for prostate cancer and either have or are at risk for ED.
What can participants expect?
Participants will be randomly assigned to either a group that receives shockwave therapy or one that does not (the control group). Those in the control group will have the opportunity to receive shockwave therapy after the one-month follow-up appointment.
For those receiving therapy as part of the clinical trial, shockwaves will be delivered to the penis tissue twice a week for three weeks.
The full length of the study is six months. All appointments last about 30 minutes.
What will participants be required to do?
- Fill out a questionnaire at the beginning and then again one month, three months, and six months after enrollment.
- Have bi-weekly appointments for weeks one, two, and three of the study.
- Have three follow-up appointments throughout the study: One month, three months and six months after enrollment
For more information contact: